Zacks Investment Research downgraded shares of Covidien Plc (COV) from NEUTRAL to UNDERPERFORM on May 27, 2013, with a target price of $59.00.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on Covidien Plc (COV),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment